The iShares Nasdaq Biotechnology ETF (NASDAQGM: IBB), the largest biotech ETF by assets, and its equal-weight rival, the SPDR S&P Biotech ETF (NYSEArca: XBI) tumbled on Tuesday, extending losses that have put those bellwether biotech funds in correction territory. With Tuesday’s decline,...